Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Hepatitis C virus (HCV) exhibits genetic diversity, impacting diagnostic and therapeutic strategies.
• The E2/NS1 gene region is crucial for HCV replication and immune evasion.
• Understanding geographic variations in HCV is essential for developing effective global health interventions.

Purpose of the Study:

• To synthesize and characterize synthetic peptides from the 5'-terminus of the HCV E2/NS1 gene.
• To develop enzyme immunoassays (EIAs) for detecting HCV sequence-specific antibodies.
• To investigate geographic variability in HCV variants and their antigenic properties.

Main Methods:

• Construction of synthetic peptides representing sequences from four distinct HCV isolates.
• Development and application of EIAs for antibody detection in patient and plasma donor samples.
• Analysis of antibody prevalence and specificity related to HCV E2/NS1 gene sequences.

Main Results:

• HCV sequence-specific antibodies were detected in 22.2% of U.S. and 55.8% of Italian chronic HCV patients.
• Antibodies were found in 54.6% of U.S. and 55.6% of Japanese plasma donors with prior HCV exposure.
• A majority of chronically infected patients (58.1% U.S., 68.8% Italy) had antibodies targeting the E2/NS1 gene's 5'-terminus.
• The amino acid region 380-436 contains both variant-specific and conserved epitopes.

Conclusions:

• Genotypic variability within the HCV E2/NS1 gene leads to antigenically distinct viral variants.
• Geographic differences in HCV variants are supported by antibody detection frequencies.
• The 5'-terminus of the E2/NS1 gene is a significant target for antibodies in chronic HCV infection.